Physician profile
Ali Salami
NPI 1366459190
$4,170.63
in general payments reported to CMS, 2019-2025
33 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $370 · 2021: $785 · 2022: $778 · 2023: $450 · 2024: $357 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,222.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $838.90 | 2019-2024 | Lifevest |
| Abbott Laboratories | $636.52 | 2019-2025 | Mitraclip, Amplatzer Talisman, Amplatzer Amulet |
| Medtronic, INC. | $348.98 | 2021-2025 | Reveal Linq |
| Philips North America LLC | $325.36 | 2022-2024 | (5044) Mcot, (Ck4) Mcot |
| Boston Scientific Corporation | $303.13 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Watchman Access System |
| Heartflow, INC. | $247.19 | 2019-2025 | |
| Braemar Manufacturing, LLC | $208.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $178.83 | 2019-2023 | Xarelto |
| Edwards Lifesciences Corporation | $101.48 | 2019-2025 | Sapien 3 Ultra Resilia |
| Cvrx, INC. | $92.39 | 2023-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals Lp | $90.79 | 2019-2023 | Andexxa |
| Biotronik INC. | $87.11 | 2019-2021 | |
| Abiomed | $76.52 | 2022 | |
| Zoll Circulation INC | $67.62 | 2020 | |
| Biosense Webster, INC. | $52.01 | 2025 | Nuvision Ice Catheter |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $49.79 | 2019-2023 | |
| Amgen INC. | $48.27 | 2019-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.16 | 2022-2023 | Jardiance |
| Cleerly, INC. | $38.75 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Regeneron Healthcare Solutions, INC. | $36.29 | 2025 | Evkeeza |
| Baxter Healthcare | $35.73 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $34.32 | 2021-2023 | Camzyos |
| Biocompatibles, INC. | $30.87 | 2019 | |
| Viiv Healthcare Company | $27.71 | 2023 | Cabenuva |
| Sanofi Pasteur INC. | $24.61 | 2022 | |
| Astellas Pharma US INC | $23.51 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.74 | 2025 | |
| Ethicon US, LLC | $20.01 | 2021 | |
| Amarin Pharma, INC. | $19.98 | 2023 | |
| Z-Medica, LLC | $16.16 | 2019 | |
| Teleflex LLC | $16.10 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $14.29 | 2019 | |
| Angiodynamics, INC. | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Salami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.